Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
A Phase I Study of the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib (INLYTA) in Children with Relapsed Refractory Solid Tumors
Grant
Overview
Affiliation
Overview
Date/time Interval
November 18, 2014 - November 17, 2018
Awarded By
CHILDREN'S HOSPITAL (PHILADELPHIA)
Total Award Amount
22500.00
Direct Costs
17857.00
Sponsor Award Id
Affiliation
Contributor
Ana Galtarossa Xavier
Investigator